MediPharm Labs Corp. (LABS) short interest & options flow
TSXLABS filed its Q1 2026 earnings this morning, and the headline number is the one the company has been working toward: positive adjusted EBITDA. That milestone — combined with a month that saw the stock climb 23% before a modest pullback this week — frames this as a genuine inflection moment for a cannabis-sector name that has spent years restructuring toward profitability. Revenue…
- Market cap
- $20M
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026

LABS news and analysis
RSSNo long-form analysis yet for LABS. Pulse alerts and the live data picture are available on ORTEX.
Open LABS on ORTEX →Want the live picture for LABS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LABS — free to start on ORTEX.
Sign up for free →Open LABS on ORTEX